Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

IBM Acquires Bowstreet Inc.

Related Content

CFPB Finalizes Rule to Scale Back ECOA Protections

SEC Staff Shortens Minimum Tender Offer Period for Certain All-Cash Offerings to 10 Business Days

OCC and FDIC Issue Final Rule Prohibiting Use of Reputation Risk in Supervisory Frameworks

SEC Announces Enforcement Results for 2025

OCC Rescinds Recovery Planning Standards and Guidelines

SEC’s Compliance and Disclosure Interpretations Now Known as Corporation Finance Interpretations (CFIs)

Kansas City Fed Approves Limited Purpose Account for Kraken Financial

SEC Adopts Rules to Implement Section 16 Filing Requirements for Insiders of FPIs; Separately Adopts Conditional Exemptions to Requirements for Insiders of FPIs Incorporated in Select Countries

Paul Rosie Joins Goodwin’s Life Sciences Group in Boston

Goodwin Advises Esperion on $1.1 Billion Acquisition by ARCHIMED

Goodwin Advised Templewater on Ascensus Health Group Acquisition

Goodwin Guides Apnimed on Strategic Monetization of Shionogi-Apnimed Sleep Science (SASS) Joint Venture Stake for $150 Million and Royalties

Goodwin Advises Hodes Weill on Acquisition by Chatham Financial

Goodwin Advises Kelonia Therapeutics in Acquisition by Lilly for $7 Billion, Largest In-Vivo CAR-T Deal to Date

Goodwin Advises Obsidian Therapeutics on Merger With Galera Therapeutics and $350 Million Private Placement Financing

Weight-Loss Drug M&A Engorges Deal Values in 2025, Driven by Fat Cheque for Metsera – Dealspeak EMEA (Mergermarket)

Technology

Mergers & Acquisitions

Technology M&A